1 – 10 of 250
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
- Extreme sleep pattern in Lewy body dementia : A hypothalamic matter?
- Structural imaging findings on non-enhanced computed tomography are severely underreported in the primary care diagnostic work-up of subjective cognitive decline
- Searching for the neurite density with diffusion MRI : Challenges for biophysical modeling
- Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease
- Mapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism
- Predicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer's disease
- Association of IL1RAP-related genetic variation with cerebrospinal fluid concentration of Alzheimer-associated tau protein
- Data-driven approaches for tau-PET imaging biomarkers in Alzheimer's disease
- 2018
- Genetic characterization of amyloid-β and tau network spread